Factors associated with differences in antihypertensive drug treatment:: results from the MONICA Augsburg Population Surveys 1989/90 and 1994/95

被引:15
作者
Gasse, C [1 ]
Hense, HW [1 ]
Stieber, J [1 ]
Döring, A [1 ]
Liese, AD [1 ]
Heller, G [1 ]
Keil, U [1 ]
机构
[1] Univ Munster, Inst Epidemiol & Social Med, D-4400 Munster, Germany
来源
SOZIAL-UND PRAVENTIVMEDIZIN | 2002年 / 47卷 / 02期
关键词
antihypertensive treatment; population study; determinants; gender difference;
D O I
10.1007/BF01318395
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To investigate in a population-based sample of hypertensive men and women the impact of factors that determine frequency and pattern of anti hypertensive treatment. Methods: We used pooled data of two independent surveys conducted 1989/90 and 1994/95 in the Augsburg region among men and women aged 25 to 74 years. Co-morbidity and cardiovascular risk factors were assessed by questionnaire and examination. Multivariate and polytomous logistic regression analyses were used to assess treatment patterns adjusting for cofactors. Results: Among a total of 9 795 survey participants, 2 279 men and 1699 women were hypertensive with 30% of men and 43% of women using antihypertensive drugs. Hypercholesterolemia was unrelated and smoking even inversely related to treatment (adjusted odds ratio OR = 0.7, 95% Cl 0.56-0.92). Women were more likely to be treated than men (adjusted OR = 1.6, 95% Cl: 1.34-1.82). Furthermore, women on monotherapy used diuretics significantly more often than men (adjusted OR relative to betablocker use 2.8, 95% Cl: 1.6-4.8). Conclusions: We identified several determinants of drug treatment among hypertensives in the community. During the study period anti hypertensive treatment seemed to be determined primarily by clinical disease but not by concomitant cardiovascular risk factor status, such as male gender, smoking, or hypercholesterolemia.
引用
收藏
页码:128 / 139
页数:12
相关论文
共 30 条
[1]  
[Anonymous], 1988, ARCH INTERN MED, V148, P1023
[2]  
[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI DOI 10.1016/0895-4356(88)90084-4
[3]   Polypharmacy: Correlations with sex, age and drug regimen - A prescription database study [J].
Bjerrum, L ;
Sogaard, J ;
Hallas, J ;
Kragstrup, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :197-202
[4]  
BRAY GA, 1978, INT J OBESITY, V2, P99
[5]  
CARPENTIER P, 1994, PRESSE MED, V23, P197
[6]   BLOOD-PRESSURE, ANTIHYPERTENSIVE DRUG-TREATMENT AND THE RISKS OF STROKE AND OF CORONARY HEART-DISEASE [J].
COLLINS, R ;
MACMAHON, S .
BRITISH MEDICAL BULLETIN, 1994, 50 (02) :272-298
[7]  
*DTSCH LIG BEK HOH, 1990, EMPF HOCHD PRAX BEH
[8]  
*DTSCH LIG BEK HOH, 1988, EMPF HOCHD PRAX BEH
[9]  
*DTSCH LIG BEK HOH, 1994, EMPF HOCHD PRAX BEH
[10]  
Estacio RO, 1998, AM J CARDIOL, V82, p9R